BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25323306)

  • 21. Stephania Tetrandra and Ginseng-Containing Chinese Herbal Formulation NSENL Reverses Cisplatin Resistance in Lung Cancer Xenografts.
    Jin L; Xu M; Luo XH; Zhu XF
    Am J Chin Med; 2017; 45(2):385-401. PubMed ID: 28231742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect and mechanism of vinorelbine on cisplatin resistance of human lung cancer cell line A549/DDP].
    Qi C; Gao S; Li H; Gao W
    Zhongguo Fei Ai Za Zhi; 2014 Feb; 17(2):148-54. PubMed ID: 24581167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.
    Xu Y; Xia F; Ma L; Shan J; Shen J; Yang Z; Liu J; Cui Y; Bian X; Bie P; Qian C
    Cancer Lett; 2011 Nov; 310(2):160-9. PubMed ID: 21802841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased sensitivity of human lung adenocarcinoma cells to cisplatin associated with downregulated contactin-1.
    Zhang R; Yao W; Qian P; Li Y; Jiang C; Ao Z; Qian G; Wang C; Wu G; Li J; Ji F; Xu J
    Biomed Pharmacother; 2015 Apr; 71():172-84. PubMed ID: 25960233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
    Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X
    Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
    Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
    Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer.
    Lu L; Zhang X; Zhang B; Wu J; Zhang X
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2530-40. PubMed ID: 23974008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine-induced killer cells induce apoptosis and inhibit the Akt/nuclear factor-κB signaling pathway in cisplatin-resistant human glioma U87MG cells.
    Cui Y; Yang F; He L
    Mol Med Rep; 2015 Nov; 12(5):7027-32. PubMed ID: 26299434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.
    Moriya Y; Nohata N; Kinoshita T; Mutallip M; Okamoto T; Yoshida S; Suzuki M; Yoshino I; Seki N
    J Hum Genet; 2012 Jan; 57(1):38-45. PubMed ID: 22089643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of cisplatin resistance in non-small cell lung cancer stem cells by Taxus chinensis var.
    Jiang YQ; Xu XP; Guo QM; Xu XC; Liu QY; An SH; Xu JL; Su F; Tai JB
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of the miR-212/132 cluster suppresses proliferation of human lung cancer cells.
    Jiang X; Chen X; Chen L; Ma Y; Zhou L; Qi Q; Liu Y; Zhang S; Luo J; Zhou X
    Oncol Rep; 2015 Feb; 33(2):705-12. PubMed ID: 25435090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multifunctional polyamidoamine-modified selenium nanoparticles dual-delivering siRNA and cisplatin to A549/DDP cells for reversal multidrug resistance.
    Zheng W; Cao C; Liu Y; Yu Q; Zheng C; Sun D; Ren X; Liu J
    Acta Biomater; 2015 Jan; 11():368-80. PubMed ID: 25204523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells.
    Huang H; Li T; Chen M; Liu F; Wu H; Wang J; Chen J; Li X
    Cell Mol Biol Lett; 2018; 23():54. PubMed ID: 30505321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
    Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
    Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
    Zhang X; Huang L; Zhao Y; Tan W
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):995-1001. PubMed ID: 24145606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal effect of adenovirus-mediated human interleukin 24 transfection on the cisplatin resistance of A549/DDP lung cancer cells.
    Xu M; Tang X; Guo J; Sun W; Tang F
    Oncol Rep; 2017 Nov; 38(5):2843-2851. PubMed ID: 29048638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells.
    Fu X; Tian J; Zhang L; Chen Y; Hao Q
    FEBS Lett; 2012 May; 586(9):1279-86. PubMed ID: 22465665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
    Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
    Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway.
    Zhang J; Zhang T; Ti X; Shi J; Wu C; Ren X; Yin H
    Biochem Biophys Res Commun; 2010 Aug; 399(1):1-6. PubMed ID: 20627087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.